Recent Advances in Metal-based Drugs in Cancer Therapy
Open Access
- 30 April 2025
- journal article
- Published by International Academic Publishing House in INTERNATIONAL JOURNAL OF EXPERIMENTAL RESEARCH AND REVIEW
- Vol. 47, 120-132
Abstract
The distinctive attributes of metals, for example, their redox activity, varied coordination modes, and reactivity against biomolecules have drawn a lot of attention to the therapeutic potential of metal complexes against various diseases. These characteristics make them a desirable probe for the development of metallodrugs that bind to the targeted biomolecules selectively and change the cellular mechanism of proliferation. Metal-based drugs have appeared as propitious candidates for cancer treatment attributable to their exceptional structural features and versatile modes of action. Recently, a substantial advancement has been made in the development of metal-based compounds with enhanced effectiveness and reduced toxicity profiles. Numerous metallodrugs have been assessed both in vitro and in vivo, with a few even progressing to clinical trials. Nevertheless, it is still challenging to find novel chemical formulations and therapeutic approaches that can specifically target cancer cells while sparing healthy cells. For many types of cancer, there are still few treatment choices available, despite advancements that have been directed to the design of novel therapeutics. This review article provides an outline of the up-to-date advancements in the field of metallodrugs for cancer treatment.Keywords
This publication has 87 references indexed in Scilit:
- Leveraging supramolecular systems in biomedical breakthroughsBioFactors, 2025
- Supramolecular Co (II) Complex Fabricated From Adenine Derivative: Synthesis, Crystal Structure, Hirshfeld Surface, DFT Optimization, Anticancer, and Molecular Docking StudiesApplied Organometallic Chemistry, 2024
- Challenges and Future Opportunities in Rare Genetic Disorders: A Comprehensive Review2024
- An Updated Review on Recent Advances in the Usage of Novel Therapeutic Peptides for Breast Cancer TreatmentInternational Journal of Peptide Research and Therapeutics, 2023
- Recent Advances of Metal-Based Anticancer Agents and Their In Vivo Potential Against Various Types of Malignancies2022
- Melatonin Induced in Cancer as a Frame of Zebrafish Model2022
- Supramolecular Properties Directed by Weak Interactions in a Copper (II) Complex Based on 8-Hydroxy Quinoline-Pyridine Binary Ligand Systems: Crystal Structure and Hirshfeld Surface AnalysesJournal of Chemical Crystallography, 2021
- Pyridine‐Based Macrocyclic and Open Receptors for UreaChemistrySelect, 2019
- Calix[4]pyrrole‐Based Heteroditopic Ion‐Pair Receptor That Displays Anion‐Modulated, Cation‐Binding BehaviorChemistry – A European Journal, 2012
- Oligoether‐Strapped Calix[4]pyrrole: An Ion‐Pair Receptor Displaying Cation‐Dependent Chloride Anion TransportChemistry – A European Journal, 2012